|
Post by kc on Oct 12, 2017 12:26:42 GMT -5
Stock price is taking off. What the he ll did he say??? PPS is going up as the shares were sold at $6.00 and the market is now reacting to it. Who bought the shares? One entity or multiple. if it ends up being 1 or 2 entities that would be extremely bullish......
|
|
|
Post by kc on Oct 12, 2017 11:04:53 GMT -5
Darn
|
|
|
Post by kc on Oct 12, 2017 11:01:16 GMT -5
still going? I just tuned in but its a commercial
|
|
|
Post by kc on Oct 12, 2017 10:57:11 GMT -5
This was actually my first thought. Has there been any scripts previously in PR? Not to mention sadly that the folks there aren't exactly eating normal meals at normal times. If at all. News reports very grim ----------- Colleagues Let me propose a positive viewpoint. There are many competent physicians and diabetologists in Puerto Rico, and it has a respected University and Medical School, whose faculty I am sure are on the front lines of public health efforts to deal with this humanitarian disaster. The donation makes obvious sense because of the easier storage and transportability of Afrezza. Puerto Rico also has a population familiar with pharmaceutical technologies, as many drug companies have a presence on the Island, and thus many clinical trials have been done there. Since it requires a prescription, it will be accessible through physicians who will dispense it prudently. I'm certain the distribution details have been well thought through by the company, and with Afrezza's safety profile and PK dynamics, patient risk is diminished. I see this as a humanitarian effort that greatly reminds me of Al Mann. More companies in the United States (IMO) might take a lesson by looking up from their balance sheets and bonus calculations to try to do some good in the world (AAPL comes to mind), and P.R. would be a great opportunity to do it. Given the diminishing reputation of the United States on the global landscape, anything done by us that demonstrates our sense of humanity is a good development, IMO. If it gives the company and drug new exposure (as it clearly does) that is an added bonus. I'll say it again, Michael Castagna is a smart CEO who knows exactly what he's doing, and many people in the market care about the reputation and perceived skill of a company's leader. When he delivers what he promises, and more, it adds to his credibility and perceived integrity. Goodl luck to all longs. Chris-C I would give them six months worth of product and engage the hospitals there as a humanitarian opportunity and what would it cost the company? Very little. if they have produced product that might otherwise spoil in date expiration.
Most of PR is lower economic and on Medicare or Medicaid.
|
|
|
Post by kc on Oct 12, 2017 10:54:21 GMT -5
Either her or Sports!.... I mean Leanne is always fast at getting the news. I'm not sure she sleeps.
|
|
|
Post by kc on Oct 12, 2017 10:34:31 GMT -5
Can someone clarify something for me....10.7 million shares at $6.00 will give the company around 58million cash. The deal is supposed to close on the 13th...that's Friday the 13th. But the share price will likely be lower than that as it's almost $5.00 now. So how does MNKD still come up $58 million? From the press release: Nothing is guaranteed, but the release stated that the price of $6 had been agreed upon with investors for a direct offering. I hope the direct offering is something they can't liquidate anytime soon and that hopefully that direct offering was purchased by one party being a partner who really wants to see MannKind thrive and grow. Perhaps a partner in the Pharma business? You just never know until we learn about it from filings. If it was one party then there would have to be a 13 D or F filing made within 45 days as it would be a stake over 5% of the company.
This would really be HUGE if it was a single buyer of the shares. It would show great confidence in the company and would stabilize the stock value for a long time going forward.
|
|
|
Post by kc on Oct 12, 2017 10:30:18 GMT -5
Well, sla beat me on it. Now I understand what others are saying. LOL It shows on the tombstone a completed deal? I would say there would be a serious legal issue for both MannKind and HC Wainwright if it turns out not to be a finalized deal?
So it has to be completed....... I hope it is as otherwise this would be a devastating blow to all of us.
|
|
|
Post by kc on Oct 12, 2017 10:27:14 GMT -5
I own shares in Check Cap which is on this page. Its an Israeli company that has great potential with an management team that has had winners before.
|
|
|
Post by kc on Oct 11, 2017 16:37:51 GMT -5
I like this language:
We are offering 10,166,600 shares of our common stock directly to certain institutional and other investors pursuant to this prospectus supplement and the accompanying prospectus. Each share of common stock is being sold at a negotiated price of $6.00. Our common stock is traded on The NASDAQ Global Market and the Tel Aviv Stock Exchange under the symbol “MNKD.” On October 10, 2017, the last reported sale price of our common stock as reported on The NASDAQ Global Market was $6.71 per share.
We have retained H.C. Wainwright & Co., LLC to act as our exclusive placement agent (“placement agent”) in connection with the shares of common stock offered by this prospectus supplement. The placement agent has agreed to use its reasonable best efforts to arrange for the sale of the common stock offered by this prospectus supplement. The placement agent is not purchasing or selling any of the shares of common stock we are offering and the placement agent is not required to arrange the purchase or sale of any specific number of shares or dollar amount. We have agreed to pay to the placement agent the placement agent fees set forth in the table below, which assumes that we sell all of the common stock offered by this prospectus supplement. All sales will be evidenced by separate securities purchase agreements between us and the investors. See “Plan of Distribution” on page S-8 of this prospectus supplement for more information regarding these arrangements
investors.mannkindcorp.com/secfiling.cfm?filingid=1193125-17-307995&CIK=899460
|
|
|
Post by kc on Oct 11, 2017 16:31:10 GMT -5
Who is Edward D. Silvera seems he is a smart young Wall Street guy. / only 7 years out of Law school.
Experience H.C. Wainwright & Co., LLC
Supervisory Head of Investment Banking & Chief Operating Officer
Company Name H.C. Wainwright & Co., LLC
Dates Employed May 2016 – Jan 2017
Employment Duration •9 mos
Location New York, NY H.C. Wainwright & Co., LLC
Chief Compliance Officer
Company Name H.C. Wainwright & Co., LLC
Dates Employed Jun 2014 – May 2016
Employment Duration •2 yrs
Location New York, NY
Series 7, 63, 24, 79, 87 certified. H.C. Wainwright & Co., LLC
Associate - Legal & Compliance
Company Name H.C. Wainwright & Co., LLC
Dates Employed Jun 2013 – Jun 2014
Employment Duration •1 yr 1 mo
Location New York, New York
Global Fund Exchange Ltd.
Trading and Settlements, Manager
Company Name Global Fund Exchange Ltd.
Dates Employed Nov 2011 – Jun 2013
Employment Duration •1 yr 8 mos
Location Oyster Bay, NY
• Report directly to CEO and Chairman. • Instituted repeatable control design for subscription-redemption processes at multi-manager fund of hedge funds to optimize accuracy of trades pursuant to underlying offshore investment offering memoranda. • Serve as subject matter expert on underlying funds’ terms of liquidity, synthesizing legal issues for CEO and Chairman. • Manage project execution for internal compliance procedures and employee processes. Originated and handle regular performance and trading analytic reports for internal NAV disparity, redemption audits and weekly-monthly valuations. • Apply qualitative and legal analysis on offering memoranda, subscription documents, relevant regulation and due diligence questionnaires of prospective offshore hedge funds and ETFs within niche sectors of agriculture, clean energy, energy, natural resources and water. • Conduct research for CEO and Chairman on Investment Advisers Act of 1940, Investment Company Act of 1940, Dodd-Frank, SEC Registration, Form PF and Form ADV, JOBS Act, CAIA due diligence questionnaires and mutual fund/UCIT regulation domestically and offshore (i.e., Cayman Islands, BVI, Ireland, Singapore). • Work closely with Comptroller liaising between independent auditor and underlying funds to compile hedge fund investment confirms, audited financials, LOAs, and executive broker letters. • Authored sales processes and drafted over 12 investment proposals for sovereign wealth funds and institutional investors. • Draft non-disclosure agreements, third party marketer agreements, website disclosures and factsheet waivers. • Track daily fund performance compared to benchmarks. Judge Stuart M. Bernstein, U.S. Bankruptcy Court, Southern District of New York
Summer Intern
Company Name Judge Stuart M. Bernstein, U.S. Bankruptcy Court, Southern District of New York
Dates Employed Jun 2010 – Aug 2010
Employment Duration •3 mos
Organized, researched, and drafted opinion segments and memoranda of law. Synthesized transcripts and trial evidence for opinions. Performed extensive cite-checking for opinion drafts. Observed hearings and trials on a variety of matters, including Chapter 11 restructurings, Chapter 7 liquidations, and Chapter 15 international bankruptcies. Debriefed with law clerks following trials, hearings, and adversary proceedings. Attended weekly summer intern course taught by Judge Robert E. Gerber.
Education Syracuse University College of Law
Syracuse University College of Law Degree Name J.D, Field Of Study Law
Dates attended or expected graduation 2009 – 2011
Alternative Dispute Resolution Club Treasurer (2009–11), Coach- Securities Dispute (2010) Coach- ABA Negotiation (2010), College Champion- In-House Tournament (2009)
Securities Arbitration and Consumer Law Clinic, Student-Attorney (Spring 2011)
Student Bar Association, Treasurer (2010–11), 2L Senator & Community Service Committee (2009–10)
Pro Bono Bankruptcy Program, Participant (2009–10)
Corporate Law Society, Vice President (2009–10)
Jewish Law Student Association, President (2010–11), Vice President (2009–10)
Brandeis University
Brandeis University Degree Name B.A, Field Of Study American Studies
Dates attended or expected graduation 2004 – 2008
Dean’s List, 3 semesters Alpha Epsilon Pi Fraternity, Lambda Beta Chapter, 4 positions Business Club, Vice President of Marketing Mosaic Program, Ambassador
|
|
|
Post by kc on Oct 11, 2017 16:17:22 GMT -5
Visiting Seattle last week opened my eyes to Cannabis. I had no idea where it was heading about see both the Gates Institute and the Paul Allen Institute being engaged in the Cannabis market. Dosing Medical Pot will be huge to some entity. The tour bus driver on my way to the Boeing aircraft factory Kept talking about the Paul Allen Institute as we drove by it and that Allen is suffering from a mile case of Parkinson's and Alzheimer's both diseases that might be good for Technosphere. Parkinson's for Cannabis and Alzheimer's for inhaled Insulin which the University of Washington has already done studies on Inhaled (nasal) insulin. They just might want to try it with Technosphere.
This article from 2015 shows the U of W study with a Technosphere being in the image. www.psychiatryadvisor.com/alzheimers-disease-and-dementia/inhaled-insulin-improves-memory-dementia-treatment/article/430731/
|
|
|
Post by kc on Oct 11, 2017 15:56:08 GMT -5
I posted last night that completing the stock offering to gain $60 million was smart, smart, smart. Even after the large pps drop today, I say again smart, smart, smart. It was likely that the continuous up days was going to come to an end in the near future anyway. The pps needs to have a period of consolidation to build a new base. What Mike C. and team did was take advantage of a high share price to get top dollar on a very modest 10% dilution. What does that get us. At a burn rate of approximately $7 million a month, that's over 8 months of operating expenses. Granted there is debt due, but they may be able to renegotiate due dates for that. Add any move up in script revenue and that runway just gets longer. It's been a great week for MannKind longs. The move was actually a genius one by Mike and the Board of Directors. Think about this. They sold it to a party who knew what they were buying a set price. The party was getting shares they could’ve bought on the open market and it would not have helped the company. Instead they bought the shares at a fixed price which leads me to believe there is more to the transaction then we know today. The question I would like to have answered is: Did they sell it to an institutional investor or to company who might eventually buy in? Of course we have to deal with the 5% disclosure rule but they do not have to give that disclosure for many days past the transaction date. I believe they have 45 days from the transaction date to file their form 13 D or G. So perhaps there is smoke and a fire beginning or perhaps there is nothing to see here. Time will tell when there is a disclosure of any new owner of shares over 5%.
|
|
|
Post by kc on Oct 10, 2017 23:43:58 GMT -5
I actually saw MNKD on the CNBC ticker in my car on Sirius Radio this morning! Very, very few stocks ever make it to Sirius Radio, and other than the major indices, it's a somewhat peculiar lot, but there is one that is not a household name that is either way or or way down. It's obvious which one we were today. You were correct in that being on the various financial channel Scrolls the last two weeks has brought the company a lot of new attention in investors. That’s a good thing for all of us
|
|
|
Post by kc on Oct 10, 2017 23:35:20 GMT -5
I agree with all the above comments. All I can say is job well done by MIKE and the entire team.
The company has received very positive attention the last two weeks and the fact it has been one of the top moving stocks in terms of PPS and volume has put it in the forefront on the daily scrolls on the various business channels. I believe this will help bring a lot of new investors in so hopefully the price will stay in the $6.00 range. Selling $60 million dollars in stock is not an easy thing but it was handled in a very professional manner. Let’s hope that these new investors will become permanent institutional grade equity. The company would be a much better footing if there were more institutional owners. Perhaps this will open that door for that to happen.
|
|
|
Post by kc on Oct 10, 2017 17:05:16 GMT -5
Holy crap! Loan rate at IB is 242 % !! The only logical explanation is Big Pharma's shorting for the possibility of a better price on buyout of mnkd. Otoh, how could they all be working together? Only one would be able to aquire mnkd/afrezza. There has never been any logical explanation for it. I used to call it my MannKind Divided. It paid daily so that one could increase their shares.
|
|